4.6 Article

The Parkinson's disease kinase LRRK2 autophosphorylates its GTPase domain at multiple sites

Journal

Publisher

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.bbrc.2009.08.163

Keywords

Parkinson's disease; Kinase; GTPase; Autophosphorylation

Funding

  1. NIH
  2. National Institute on Aging [AG000948-01]
  3. National Institute of Neurological Diseases and Stroke
  4. Flemish Fund for Scientific Research FWO Vlaanderen [G.0406.06, G.0666.09, NS062287]

Ask authors/readers for more resources

Mutations in leucine-rich repeat kinase 2 (LRRK2) are a common Cause of inherited Parkinson's disease (PD). The protein is large and complex, but pathogenic mutations cluster in a region containing GTPase and kinase domains. LRRK2 can autophosphorylate in vitro within a dimer pair, although the significance of this reaction is unclear. Here, we mapped the sites of autophosphorylation within LRRK2 and found several potential phosphorylation sites within the GTPase domain. Using mass spectrometry, we found that Thr1343 is phosphorylated and, using kinase dead versions of LRRK2, show that this is an autophosphorylation site. However, we also find evidence for additional sites in the GTPase domain and in other regions of the protein suggesting that there may be multiple autophosphorylation sites within LRRK2. These data suggest that the kinase and GTPase activities of LRRK2 may exhibit complex autoregulatory interdependence. Published by Elsevier Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available